Centrum Medyczne Clw-Med Aneta Cichomska I Joanna Luka-Wendrowska Sp. j.

The hospital is evaluating a biosimilar for ulcerative colitis. Another study examines treatment options for idiopathic or diabetic gastroparesis. Research aims to improve remission rates and patient quality of life.

• Biosimilar AVT16 versus Entyvio for ulcerative colitis
• Oral mesalazine formulation for induction of remission in ulcerative colitis
• Naronapride efficacy in idiopathic and diabetic gastroparesis
• Clinical remission assessment criteria in ulcerative colitis

Centrum Medyczne Clw-Med conducts five trials with two investigators at its Grudziadz, Poland location, offering both adult and pediatric participation in a hospital setting.

A trial is testing a nasal spray for acute rhinitis. Additional research targets symptom relief in rhinopharyngitis and rhinosinusitis without the use of antibiotics. The goal is to demonstrate safety and effectiveness of non‑systemic therapy.

• Actisoufre nasal spray efficacy in acute rhinitis
• Placebo‑controlled study of nasal spray for rhinopharyngitis
• Symptom improvement in rhinosinusitis without antibiotics
• Pediatric assessment of nasal spray safety and benefit

The Grudziadz‑based clinic supports five clinical studies, led by two investigators, focusing on non‑antibiotic management of common respiratory infections.